Literature DB >> 16419614

Toll-like receptors. II. Distribution and pathways involved in TLR signalling.

F Sandor1, M Buc.   

Abstract

The innate immune system senses invading microorganisms by a phylogenetically conserved family of proteins--TLRs. They are expressed in several types of cells that represent a route of entry of pathogens into the host organism and that can contribute to protection against infection. Except for cells of the immune system, TLRs are present in epithelial cells of the skin, respiratory, intestinal, and genitourinary tracts that form the first protective barrier to invading pathogens. Polarized regulation of TLR expression in epithelial cells explains why pathogenic but not commensal bacteria elicit inflammatory responses. TLR-induced intracellular signalling pathways show remarkable complexity: apart from a common signalling pathway, additional signalling pathways specific for each of the TLRs are responsible for a fine tuning of the immune response, thus securing effective pathogen-directed biological responses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16419614

Source DB:  PubMed          Journal:  Folia Biol (Praha)        ISSN: 0015-5500            Impact factor:   0.906


  23 in total

Review 1.  Mucins and toll-like receptors: kith and kin in infection and cancer.

Authors:  Shikha Tarang; Sushil Kumar; Surinder K Batra
Journal:  Cancer Lett       Date:  2012-02-03       Impact factor: 8.679

2.  The genetic background influences the cellular and humoral immune responses to vaccines.

Authors:  M Zeng; E Nourishirazi; E Guinet; M Nouri-Shirazi
Journal:  Clin Exp Immunol       Date:  2016-08-16       Impact factor: 4.330

3.  TLR4 activation induces nontolerant inflammatory response in endothelial cells.

Authors:  Wenmeng Wang; Minjie Deng; Xueting Liu; Wen Ai; Qizhu Tang; Jinyue Hu
Journal:  Inflammation       Date:  2011-12       Impact factor: 4.092

4.  Toll-like receptor and innate cytokine responses induced by lactobacilli colonization and human rotavirus infection in gnotobiotic pigs.

Authors:  Ke Wen; Marli S P Azevedo; Ana Gonzalez; Wei Zhang; Linda J Saif; Guohua Li; Ahmed Yousef; Lijuan Yuan
Journal:  Vet Immunol Immunopathol       Date:  2008-10-31       Impact factor: 2.046

5.  Phosphodiesterase 4B2 gene is an effector of Toll-like receptor signaling in astrocytes.

Authors:  Elizabeth Borysiewicz; Daniel Fil; Daniel Dlaboga; James M O'Donnell; Gregory W Konat
Journal:  Metab Brain Dis       Date:  2009-09       Impact factor: 3.584

6.  Combination of TLR8 and TLR4 agonists reduces the degrading effects of nicotine on DC-NK mediated effector T cell generation.

Authors:  Mahyar Nouri-Shirazi; Saba Tamjidi; Erika Nourishirazi; Elisabeth Guinet
Journal:  Int Immunopharmacol       Date:  2018-05-24       Impact factor: 4.932

7.  The expression of cytokines in the aqueous humor and serum during endotoxin-induced uveitis in C3H/HeN mice.

Authors:  Yingzhi Xu; Wei Chen; Hong Lu; Xiaofeng Hu; Shang Li; Jing Wang; Li Zhao
Journal:  Mol Vis       Date:  2010-08-21       Impact factor: 2.367

8.  Molecular basis of cytotoxicity of Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) in EBV latency III B cells: LMP1 induces type II ligand-independent autoactivation of CD95/Fas with caspase 8-mediated apoptosis.

Authors:  Christophe Le Clorennec; Tan-Sothéa Ouk; Ibtissam Youlyouz-Marfak; Stéphanie Panteix; Catherine-Claude Martin; Julia Rastelli; Eric Adriaenssens; Ursula Zimber-Strobl; Jean Coll; Jean Feuillard; Chantal Jayat-Vignoles
Journal:  J Virol       Date:  2008-04-30       Impact factor: 5.103

9.  Expression of toll-like receptor 4 in uvea-resident tissue macrophages during endotoxin-induced uveitis.

Authors:  Wei Chen; Xiaofeng Hu; Li Zhao; Shang Li; Hong Lu
Journal:  Mol Vis       Date:  2009-03-30       Impact factor: 2.367

10.  Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells.

Authors:  Satya Prakash; Aleksandra Malgorzata Urbanska
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.